Early Xenopus laevis embryogenesis is a robust system for investigating mechanisms of developmental timing. After a series of rapid cell divisions with concomitant reductions in cell size, the first major developmental transition is the midblastula transition (MBT), when zygotic transcription begins and cell cycles elongate [1] [2] [3] . Whereas the maintenance of a constant nuclear-to-cytoplasmic (N/C) volume ratio is a conserved cellular property [4] [5] [6] [7] , it has long been recognized that the N/C volume ratio changes dramatically during early Xenopus development [8] . We investigated how changes in nuclear size and the N/C volume ratio during early development contribute to the regulation of MBT timing. Whereas previous studies suggested a role for the N/C volume ratio in MBT timing [1, [9] [10] [11] [12] [13] , none directly tested the effects of altering nuclear size. In this study, we first quantify blastomere and nuclear sizes in X. laevis embryos, demonstrating that the N/C volume ratio increases prior to the MBT. We then manipulate nuclear volume in embryos by microinjecting different nuclear scaling factors, including import proteins, lamins, and reticulons. Using this approach, we show that increasing the N/C volume ratio in pre-MBT embryos leads to premature activation of zygotic gene transcription and early onset of longer cell cycles. Conversely, decreasing the N/C volume ratio delays zygotic transcription and leads to additional rapid cell divisions. Whereas the DNA-to-cytoplasmic ratio has been implicated in MBT timing [1, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , our data show that nuclear size also contributes to the regulation of MBT timing, demonstrating the functional significance of nuclear size during development.
Summary
Early Xenopus laevis embryogenesis is a robust system for investigating mechanisms of developmental timing. After a series of rapid cell divisions with concomitant reductions in cell size, the first major developmental transition is the midblastula transition (MBT), when zygotic transcription begins and cell cycles elongate [1] [2] [3] . Whereas the maintenance of a constant nuclear-to-cytoplasmic (N/C) volume ratio is a conserved cellular property [4] [5] [6] [7] , it has long been recognized that the N/C volume ratio changes dramatically during early Xenopus development [8] . We investigated how changes in nuclear size and the N/C volume ratio during early development contribute to the regulation of MBT timing. Whereas previous studies suggested a role for the N/C volume ratio in MBT timing [1, [9] [10] [11] [12] [13] , none directly tested the effects of altering nuclear size. In this study, we first quantify blastomere and nuclear sizes in X. laevis embryos, demonstrating that the N/C volume ratio increases prior to the MBT. We then manipulate nuclear volume in embryos by microinjecting different nuclear scaling factors, including import proteins, lamins, and reticulons. Using this approach, we show that increasing the N/C volume ratio in pre-MBT embryos leads to premature activation of zygotic gene transcription and early onset of longer cell cycles. Conversely, decreasing the N/C volume ratio delays zygotic transcription and leads to additional rapid cell divisions. Whereas the DNA-to-cytoplasmic ratio has been implicated in MBT timing [1, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , our data show that nuclear size also contributes to the regulation of MBT timing, demonstrating the functional significance of nuclear size during development.
Results
Nuclear and Cell Volumes Become Progressively Smaller during Xenopus Early Development, with the N/C Volume Ratio Increasing prior to the MBT The first major developmental transition during early X. laevis embryogenesis is the midblastula transition (MBT). Approximately 1.5 hr after fertilization, 12 rapid synchronous cleavage cell cycles ensue, each about 25-30 min long and consisting of alternating S and M phases [1, 2] . Next, cell cycles lengthen with the acquisition of gap phases and major zygotic transcription begins, marking the MBT (Nieuwkoop-Faber stage 8, cleavage 12) [14, 19] . Initially a 1.2 mm single cell, the embryo consists of several thousand 50 mm and smaller blastomeres at the MBT.
To determine nuclear scaling relationships during X. laevis development, we isolated blastomeres from embryos at different developmental stages ( Figure 1A ) and quantified cell and nuclear sizes (Figures S1A and S1B available online). Average nuclear volume scaled progressively smaller with cytoplasmic volume in all early stages examined ( Figure 1B) . From stages 4 to 8 (cleavage 12), nuclear volume decreased on average w3-fold whereas cytoplasmic volume showed a much more dramatic w70-fold reduction in volume ( Figure 1B) . Within a given stage, we observed large differences in blastomere size [20] , and nuclear and cell sizes tended to scale within a given stage (Figures S1A and S1B).
Although absolute nuclear size was greater in earlier developmental stages, nuclei in later-stage embryos occupied proportionately more of the cell. To quantify this effect, we calculated nuclear-to-cytoplasmic (N/C) volume ratio values on a per cell basis and found that the average N/C volume ratio increased prior to the MBT (stage 8, cleavage 12), reaching a maximum at stage 9 ( Figures 1C, 2C , and S1H). These data prompted us to test if the N/C volume ratio plays a role in regulating timing of the MBT.
Manipulating Nuclear Size and the N/C Volume Ratio in Xenopus Embryos
To determine how nuclear size and the N/C volume ratio might impact developmental progression, we sought multiple approaches employing different mechanisms to manipulate nuclear size in the embryo, utilizing factors known to regulate nuclear size: importins, lamins, and reticulons [21, 22] . Previous work in Xenopus egg extracts and early embryos demonstrated that rates of nuclear import influence nuclear size, with the levels of importin a being particularly important [23] . An importin a cargo essential for nuclear envelope (NE) growth and for regulating nuclear size is lamin B3 (LB3), the primary lamin present in the egg and early embryo that is a major constituent of the nuclear lamina [24] [25] [26] . Because the NE and ER are continuous, the structure of the ER also impacts nuclear size. Proteins in the reticulon (Rtn) family mediate ER tubule formation [27, 28] , and Rtn4 overexpression converts ER sheets to tubules and decreases nuclear size in tissue culture cells [29, 30] .
We first tested if increasing the levels of importin a and LB3 would affect nuclear size in the embryo. Fertilized one-cell X. laevis embryos were microinjected with a range of mRNA amounts to titrate the expression levels of importin a and GFP-LB3, and nuclear size was quantified in stage 8 embryos (cleavage 12; 7 hr postfertilization [hpf]). Whereas ectopic expression of either importin a or GFP-LB3 increased nuclear size, coexpression had a greater effect (Figures 2A and S1C -S1E). Effects of importin a and LB3 expression on nuclear size were more dramatic when quantified in embryos at stage 6 (3.5 hpf; Figure 2B ) compared to stage 8 (7 hpf; Figure 2A ).
To identify an approach to altering nuclear size that does not directly involve nucleocytoplasmic transport or lamins, we focused on ER structure and reticulons. Ectopic expression of GFP-Rtn4a in X. laevis embryos decreased nuclear size at all concentrations tested, consistent with results in mammalian tissue culture [30] (Figures 2A, 2B , and S1F). We also tested the smaller isoform Rtn4b. Whereas low concentrations of GFP-Rtn4b decreased nuclear size, as expected, high *Correspondence: dlevy1@uwyo.edu expression levels increased nuclear size (Figures 2A, 2B , and S1G). A possible explanation for this observation is that high GFP-Rtn4b concentrations led to the formation of reticulon aggregates ( Figure S2 ) that potentially act in a dominant-negative fashion by extracting reticulons from the ER, promoting ER sheet formation and increased nuclear size. For our studies, an advantage of this result is that we were able to increase (A) X. laevis embryos that were unarrested (i.e., not treated with cycloheximide) were cultured from stage 2 in calcium/magnesium-free medium within intact vitelline membranes. At desired stages, dissociated blastomeres were immediately fixed and subjected to whole-mount fluorescence immunocytochemistry staining with mAb414, an antibody against the nuclear pore complex (NPC). Nuclei within intact, roughly spherical blastomeres were visualized by confocal microscopy. Cross-sectional area was quantified for both cells and nuclei ( Figures S1A and S1B) . The right side of the panel shows representative 3D reconstructions from cell and nuclear confocal sections. Image acquisition and quantification are detailed in Supplemental Experimental Procedures. Direct volume measurements agreed within 9% and 3% of volumes extrapolated from cross-sectional areas for stage 6 and stage 8 (MBT, cleavage 12), respectively, validating our approach of estimating volumes from cross-sectional area measurements. All scale bars represent 50 mm. or decrease nuclear size by manipulating the levels of the same factor.
Having identified multiple conditions that increase or decrease nuclear size in the embryo, we next determined how these manipulations affected the N/C volume ratios of individual cells. In stage 5 and 6 embryos with increased nuclear size, the average N/C volume ratio increased to a value larger than that found in wild-type stage 7 embryos, and the spread of these values also became greater ( Figure 2C ). This effect was more pronounced in stage 6.5 and 7 embryos, with injected stage 7 embryos having the same average and spread of N/C volume ratios as untreated stage 8 embryos ( Figures 2C and S1H ). Even though the average N/C volume ratio in stage 5-6.5 embryos with increased nuclear size did not reach that of MBT embryos, we noted that many individual cells had N/C volume ratios that overlapped with the lower range found in stage 8 MBT blastomeres ( Figure 2C ). These observations led us to test if the MBT might be initiated earlier in these blastomeres upon reaching a threshold N/C volume ratio. Conversely, in stage 8 embryos with reduced nuclear size, the average N/C volume ratio decreased w5-fold. Many individual blastomeres with decreased nuclear size had N/C volume ratios characteristic of A C B Figure 2 . Manipulating Nuclear Size and the N/C Volume Ratio in X. laevis Embryos (A) One-cell embryos were microinjected with the most effective amounts of indicated mRNAs: GFP, 100 pg; Imp.a + GFP-LB3, 1,000 pg; GFP-Rtn4b high concentration, 500 pg; GFP-Rtn4a, 350 pg; and GFP-Rtn4b low concentration, 150 pg. Nuclei were isolated from stage 8 embryos and visualized by immunofluorescence using mAb414. Nuclear cross-sectional area was quantified for at least 500 nuclei from w100 embryos for each condition. One representative experiment of three is shown; error bars represent SD; ***p < 0.001. (B) Embryos were injected as described in (A). Nuclei were visualized in isolated stage 6 (3.5 hpf) blastomeres by whole-mount immunocytochemistry as described in Figure 1A . Nuclear cross-sectional area was quantified for at least 50 nuclei for each condition. One representative experiment of two is shown; error bars represent SD; ***p < 0.001. (C) Embryos were injected as described in (A). Nuclei were visualized in isolated blastomeres at the indicated stages by whole-mount immunocytochemistry, and N/C volume ratios were quantified as in Figure 1 . N/C volume ratios for individual blastomeres are plotted. N/C ratios shown in blue represent control blastomeres and were calculated from the data shown in Figures S1A and S1B. For stages [7] [8] [9] [10] [11] [12] , N/C ratios greater than 4.2% were excluded for clarity, and all of those data are plotted in Figure S1H . N/C ratios shown in red represent blastomeres with increased nuclear size (i.e., injected with importin a + GFP-LB3 or GFP-Rtn4b high concentration). N/C ratios shown in green represent blastomeres with decreased nuclear size (i.e., injected with GFP-Rtn4a or GFPRtn4b low concentration). Stage 5 blastomeres with increased nuclear size: n = 28; stage 6 blastomeres with increased nuclear size: n = 38; stage 6.5 blastomeres with increased nuclear size: n = 23; stage 7 blastomeres with increased nuclear size: n = 55; stage 8 blastomeres with decreased nuclear size: n = 83. Short, thick horizontal lines indicate mean values for each stage. The box labeled ''putative N/C volume ratio window within which MBT initiates'' denotes the overlap between wild-type stage 8 blastomeres with the smallest N/C volume ratios and stage 5-6.5 blastomeres with increased nuclear size. See also Figure S2 . Imp.α + GFP-LB3 mRNA injected embryos 
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Altering the N/C Volume Ratio Changes the Timing of the Onset of Zygotic Gene Transcription
To test if altering nuclear size in early embryos affects MBT timing, we monitored a key molecular hallmark of the MBT, onset of zygotic gene expression. We first used whole-mount in situ hybridization to detect the GS17 transcript, one of the first abundantly transcribed zygotic genes and a classical molecular marker of the MBT [31, 32] . Our approach was to alter nuclear size in half of each embryo by microinjecting one blastomere at the two-cell stage and allowing the embryo to develop ( Figure 3A) . Differential GS17 staining in the two halves of each embryo indicated altered timing for the onset of zygotic transcription. Control GFP-injected embryos showed no GS17 staining in pre-MBT stages, and at stage 8, both halves stained equally for GS17, indicating no effect on MBT timing ( Figures 3B and 3F ). Premature expression of GS17 was detected in stage 5-7 embryos when nuclear size was increased by (1) coinjection of importin a and GFP-LB3 (Figures 3C and 3F), (2) injection of the high concentration of GFP-Rtn4b ( Figures 3D and 3F ), or (3) injection of GFP-LB3 alone ( Figure 3F ). Furthermore, stage 8 embryos exhibited more intense GS17 staining in the embryo halves with increased nuclear size. We noted that not all cells in injected embryo halves showed differential staining. We quantified these cells and found that blastomeres expressing GS17 had larger N/C volume ratios than both uninjected cells and injected cells with weak or absent GS17 staining ( Figures S3A-S3D ). These data are consistent with the hypothesis that GS17 transcription initiates upon cells reaching a threshold N/C volume ratio. Conversely, decreasing nuclear size by GFP-Rtn4a mRNA microinjection led to weaker GS17 staining in late stage 8 embryos (post-MBT; 7.5 hpf), suggestive of a delay in MBT timing ( Figures 3E and 3F ). To corroborate our in situ hybridization data, we quantified additional zygotic transcripts by quantitative PCR (qPCR) [3, 33] . Stage 6.5 (4 hpf) embryos with increased nuclear size showed increased expression of three additional MBT transcripts compared to GFP control-injected embryos, up to seven times greater in some cases ( Figure 3G ). These changes in gene expression were comparable to those reported for other studies in which MBT timing was altered [34] [35] [36] . Importantly, nonzygotic transcripts did not show this trend, suggesting that the effect of nuclear size is specific to MBT transcription ( Figure S3E ). In late stage 8 embryos (7.5 hpf) with decreased nuclear size, we observed less expression of zygotic transcripts compared to control embryos ( Figure 3H ), but not reduced expression of nonzygotic transcripts ( Figure S3F ). Taken together, these results demonstrate that increasing the N/C volume ratio in pre-MBT embryos is sufficient to cause premature onset of zygotic transcription, whereas decreasing the N/C volume ratio delays zygotic gene transcription.
Altering the N/C Volume Ratio Changes the Timing of Cellular Hallmarks of the MBT Changes in the cell cycle are another key feature of the MBT. To test if altering nuclear size in early embryos affects the timing of cellular hallmarks of the MBT, we analyzed timelapse movies of microinjected embryos (Figures 4A and S4 ; Movie S1). Generally, control GFP-injected embryos cleaved synchronously until the 12 th cleavage (i.e., stage 8, the normal MBT), at which time cell cycles lengthened ( Figures 4A and  S4C ). Embryos with decreased nuclear size cleaved rapidly until, on average, the 14 th cell cycle, whereas embryos with increased nuclear size exhibited longer cell cycles after only the tenth cleavage ( Figures 4A and S4C) . To further support these observations, we quantified the number of cells and amount of genomic DNA per embryo, as a proxy for the number of cell divisions. Consistent with our time-lapse movies, 7.5 hpf embryos with increased nuclear size had considerably fewer cells and less total genomic DNA than control embryos, whereas embryos with decreased nuclear size had greater numbers of cells and more DNA at the same postfertilization time point (Figures 4B, 4C, and S4A ). In addition, as a result of altered cell-cycle timing, cell sizes differed in embryos with altered nuclear size when analyzed at 7.5 hpf ( Figures  S4A and S4B) . Furthermore, blastopore closure rates were also affected in embryos with altered nuclear size ( Figure 4D ; Movie S2).
Discussion
Our data show that nuclear and cell volumes scale progressively smaller throughout early embryogenesis, consistent with data from previous studies [8, 23] ; that the N/C volume ratio increases rapidly prior to the MBT; and that altering the N/C volume ratio leads to changes in the timing of both zygotic gene transcription and cell-cycle lengthening. We manipulated nuclear size in embryos by altering the levels of a variety of different factors, strengthening our conclusion that nuclear size impacts MBT timing and minimizing concerns about pleiotropic effects of mRNA microinjections. In particular, our reticulon injection experiments likely alter nuclear size independently of nucleocytoplasmic transport.
Stage 5-7 embryos with increased N/C volume ratios exhibited premature zygotic transcription; however, not all injected embryos and not all cells in injected embryo halves stained positive for GS17, and the average increase in zygotic gene expression was less than that occurring at the normal MBT (Figure 3) . One explanation is that nuclear size changes in a subset of cells were insufficient to increase the N/C (B-E) Embryos at the indicated stages and microinjected with the indicated mRNAs were subjected to in situ hybridization to detect the GS17 transcript. The top panels are bright-field images of embryos stained for GS17 (purple). The bottom panels are the corresponding rhodamine fluorescence images indicating cells in the embryo that received the indicated mRNA. Representative embryos are shown. (F) The top graph shows the percentage of stage 5-7 embryos in which the injected half showed GS17 staining whereas the uninjected half did not (dark purple bars). GFP: n = 57; GFP-Rtn4a: n = 42; Imp.a + GFP-LB3: n = 119; GFP-LB3: n = 124; GFP-Rtn4b high conc.: n = 139. The bottom graph shows the percentage of post-MBT (7.5 hpf) embryos in which the injected half showed weak GS17 staining relative to the uninjected half (light purple bar). GFP: n = 38; GFP-Rtn4a: n = 70. (G and H) One-cell embryos were microinjected with the indicated mRNAs to increase (G) or decrease (H) nuclear size and allowed to develop to stage 6.5 (G) or post-MBT 7.5 hpf (H). Total RNA was isolated from 12 embryos for each condition and converted to cDNA. Expression levels of three zygotic genes (xnr5-13, xnr3, and bix1.1) were determined by qPCR, normalized to ODC. Gene-expression levels are plotted in arbitrary units (AU) relative to GFP mRNA-injected control embryos. The means from two independent experiments are shown; error bars represent SD; ***p < 0.001; **p < 0.01; *p < 0.05. See also Figure S3 .
volume ratio to that associated with the MBT (Figure 2C) . Variability in the amount of mRNA received by individual cells as well as variation in cell sizes within a given embryo (Figures S1A and S1B) might account for why only some cells possessed a sufficiently increased N/C volume ratio to trigger zygotic gene expression. In support of this idea, we Cell-cycle lengths were measured for at least four cells per embryo starting at the ninth cell division for six embryos per condition. Red squares, blue diamonds, and green triangles represent average cycle lengths for embryos with increased, control, and decreased nuclear size, respectively. Data from two independent experiments are shown; error bars represent SD.
(B) One-cell embryos were microinjected with the indicated mRNAs. Stage four embryos were cultured in calcium/magnesium-free medium within intact vitelline membranes. The 7.5 hpf embryos were fixed, cells from individual embryos were dissociated in 2.5 ml of fixative, and the number of cells in 25 ml aliquots were counted and corrected for the total volume. For each condition, cells from ten embryos were counted. Means from two independent experiments are shown; error bars represent SE; ***p < 0.001; **p < 0.01; *p < 0.05. (C) One-cell embryos were microinjected with the indicated mRNAs and allowed to develop to 7.5 hpf. Genomic DNA was extracted from ten embryos for each condition, and 0.4 embryo equivalents of genomic DNA were run on a 1.2% agarose gel stained with ethidium bromide. DNA amounts were quantified using imageJ and normalized to the GFP control. Means from three independent experiments are shown; error bars represent SD; one representative gel is shown.
(D) One blastomere of a two-cell embryo was coinjected with rhodamine-labeled dextran and the indicated mRNAs to alter nuclear size. Bright-field timelapse imaging was performed on the vegetal pole of gastrulating embryos at 5 min intervals. Blastopore circumference was measured for 12 embryos per condition. Means from three independent experiments are shown; error bars represent SE; ***p < 0.001; *p < 0.05. See also Figure S4 and Movies S1 and S2.
observed a striking correlation between GS17 expression and increased N/C volume ratios when examined on a cellby-cell basis ( Figures S3A-S3D ). Taken together, our data suggest that the initiation of MBT zygotic transcription is triggered within a threshold N/C volume ratio window ( Figure 2C ). One mechanism that regulates MBT timing is the DNA-tocytoplasmic ratio [1, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . The proposed model is that maternally derived MBT inhibitors are present in a fixed volume of embryonic cytoplasm, and once a critical genomic DNA amount is reached, titration of these factors by DNA induces the MBT [1, 14] . Recently, a number of potential limiting components have been identified relevant to the Xenopus MBT [34, 37, 38] . Importantly, none of these factors appear to fully account for the abrupt changes in gene expression and cell behavior that occur at the MBT, and it seems likely that redundant mechanisms regulate this critical developmental transition [39, 40] . We show that altering the N/C volume ratio independently of ploidy affects MBT timing, thus demonstrating that nuclear size, as well as DNA amount, regulates the MBT. Interestingly, we find that increasing nuclear size affects zygotic transcription earlier than cell-cycle length. It is possible that transcription is more sensitive to nuclear size whereas DNA amount is more critical to cell-cycle changes, and there is precedence for uncoupling of these two events during the MBT [20, [41] [42] [43] [44] [45] .
Future experiments will address the relative contributions of nuclear size and DNA amount to MBT timing, and it seems likely that the two mechanisms are related. One possibility is that the effects of DNA amount on MBT timing in classical experiments [1, 14] were mediated through changes in nuclear size. Altering ploidy in Xenopus can subtly affect nuclear size. For example, haploids have smaller nuclei than diploids in early stages of development, and nuclei assembled de novo in egg extract are slightly smaller when assembled with less DNA [23] . Furthermore, previously demonstrated activation of MBT transcription by cycloheximide treatment [16, 42] may have been mediated by nuclear size changes, as nuclei grow continuously in early embryos treated with cycloheximide [23] . Early MBT induction by microinjection of plasmid DNA into embryos [14] might also have been mediated through the N/C volume ratio, as this injected DNA was subsequently shown to assemble into nuclei [46, 47] . Another possibility is that nuclear volume is relevant to models of MBT timing that invoke titration of an inhibitor by DNA binding, and a notable property of the putative limiting components identified to date is that they all act within the nucleus [34, 37, 38] . Perhaps the MBT is regulated not only by the absolute amounts of key DNA-binding factors that are maternally derived and titrated by DNA to trigger the MBT but by their nuclear concentrations, determined by changes in total embryonic nuclear volume during development.
The maintenance of a constant N/C volume ratio is a highly conserved cellular feature [4] [5] [6] [7] , and aberrations in this ratio and nuclear size are associated with certain disease states, most notably cancer [48] . Our study identifies a functional role for nuclear size in regulating developmental timing and paves the way for future research into the functional significance of nuclear size in the context of development, differentiation, and disease.
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